Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)

HKG:1349 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,887	6,602	8,057	7,767	13,434	15,730
Market Cap Growth	15.40%	-18.06%	3.73%	-42.18%	-14.60%	282.12%
Enterprise Value	6,683	5,465	6,850	6,427	12,106	14,244
Last Close Price	3.02	2.44	2.39	3.16	3.42	3.35
PE Ratio	-	156.13	67.32	49.79	51.31	80.44
Forward PE	-	22.46	22.46	22.46	22.46	22.46
PS Ratio	10.14	8.74	8.60	6.66	9.60	15.89
PB Ratio	3.20	2.69	3.10	3.05	5.00	6.60
P/TBV Ratio	3.29	2.78	3.22	3.13	5.20	6.78
P/FCF Ratio	72.68	-	-	88.13	73.56	187.64
P/OCF Ratio	48.23	-	102.98	41.57	40.70	117.22
PEG Ratio	-	0.69	0.69	0.69	0.69	0.69
EV/Sales Ratio	8.59	7.24	7.31	5.51	8.65	14.39
EV/EBITDA Ratio	-	112.28	48.18	30.41	45.55	62.59
EV/EBIT Ratio	-	-	80.59	49.83	60.61	84.03
EV/FCF Ratio	61.58	-	-	72.92	66.29	169.90
Debt / Equity Ratio	0.01	0.01	0.01	0.06	0.01	0.01
Debt / EBITDA Ratio	-	0.38	0.13	0.64	0.14	0.10
Debt / FCF Ratio	0.16	-	-	1.60	0.21	0.28
Asset Turnover	0.28	0.26	0.29	0.36	0.43	0.41
Inventory Turnover	1.88	1.40	1.76	2.27	2.26	1.95
Quick Ratio	8.40	6.08	3.60	2.98	3.56	4.63
Current Ratio	8.68	6.40	3.70	3.07	3.65	4.74
Return on Equity (ROE)	-2.73%	1.69%	4.70%	6.18%	10.12%	11.17%
Return on Assets (ROA)	-2.58%	-0.18%	1.65%	2.48%	3.85%	4.39%
Return on Invested Capital (ROIC)	-2.83%	-0.21%	2.03%	3.10%	4.79%	5.73%
Return on Capital Employed (ROCE)	-4.60%	-0.30%	3.30%	5.00%	7.20%	6.90%
Earnings Yield	-0.87%	0.64%	1.49%	2.01%	1.95%	1.24%
FCF Yield	1.38%	-0.95%	-0.38%	1.14%	1.36%	0.53%
Dividend Yield	2.22%	2.18%	3.23%	2.50%	2.51%	1.77%
Payout Ratio	-	234.79%	70.10%	51.48%	24.45%	42.37%
Buyback Yield / Dilution	24.84%	-0.23%	-0.29%	1.29%	-5.59%	-7.20%
Total Shareholder Return	27.05%	1.95%	2.94%	3.80%	-3.08%	-5.42%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.